FDA 510(k) FDA class 2 Substantially Equivalent 🇬🇧 United Kingdom

COZART RAPISCAN ORAL FLUID DRUG TEST - OPIATE/METHADONE

K Number: K020920 · Decision Nov 5, 2002
Classifications
1
FEI Numbers
100
Registration Numbers
100
Same Product Code
214
Applicant Total
6
Review Days
229

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
COZART RAPISCAN ORAL FLUID DRUG TEST - OPIATE/METHADONE
K Number
K020920
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
862.3650
Medical Specialty
Clinical Toxicology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Cozart Bioscience , Ltd.
Date Received
March 21, 2002
Decision Date
November 5, 2002
Product Code
DJG
Advisory Committee
Clinical Toxicology
Review Advisory Committee
TX
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
DJG Enzyme Immunoassay, Opiates

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (DJG), ordered by most recent decision date.

View all

Other Clearances by Cozart Bioscience , Ltd.

K Number Device Name
K033743 COZART EIA AMPHETAMINES ORAL FLUID MICROPLATE KIT
K021944 COZART EIA COTININE URINE KIT
K030234 COZART EIA COCAINE ORAL FLIUD KIT
K024339 COZART EIA OPIATES ORAL FLUID KIT
K011131 METHADONE MICROPLATE EIA URINE APPLICATION